Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?
Shenmiao Yang
◽
Neil E. Kay
◽
Min Shi
◽
Gert Ossenkoppele
◽
Roland B. Walter
◽
...
John Kim Choi
◽
Paul E. Mead
2017 ◽
Vol 31
(7)
◽
pp. 1482-1490
◽
C S Hourigan
◽
R P Gale
◽
N J Gormley
◽
G J Ossenkoppele
◽
R B Walter
2019 ◽
Vol 12
(3)
◽
pp. 671-686
◽
Wenbin Xiao
◽
Kseniya Petrova-Drus
◽
Mikhail Roshal
2020 ◽
Vol 4
(18)
◽
pp. 4573-4573
2012 ◽
Vol 5
(4)
◽
pp. 305-309
E. Grey-Davies
◽
A. Attygalle
◽
A. Wotherspoon
◽
F. Carretero
◽
A. Morilla
◽
...
2007 ◽
Vol 21
(5)
◽
pp. 956-964
◽
A C Rawstron
◽
N Villamor
◽
M Ritgen
◽
S Böttcher
◽
P Ghia
◽
...
2021 ◽
Vol 8
(12)
◽
pp. e879-e890
◽
Jacob D Soumerai
◽
Anthony R Mato
◽
Ahmet Dogan
◽
Venkatraman E Seshan
◽
Erel Joffe
◽
...
2014 ◽
Vol 383
◽
pp. S66
◽
Marwan Kwok
◽
Andy Rawstron
◽
Abraham Varghese
◽
Paul Evans
◽
Sheila O'Connor
◽
...
Jennifer M. Yoest
◽
Cara Lunn Shirai
◽
Eric J. Duncavage